Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study).

dc.contributor.authorCobo, Teresa
dc.contributor.authorAldecoa, Victoria
dc.contributor.authorBartha, José Luis
dc.contributor.authorBugatto, Fernando
dc.contributor.authorCarrillo Badillo, María Paz
dc.contributor.authorComas, Carmina
dc.contributor.authorDiago Almeda, Vicente
dc.contributor.authorFerrero, Silvia
dc.contributor.authorGoya, Maria
dc.contributor.authorHerraiz, Ignacio
dc.contributor.authorMartí Malgosa, Laia
dc.contributor.authorOlivella, Anna
dc.contributor.authorPaules, Cristina
dc.contributor.authorFerrero, Silvia
dc.contributor.authorFigueras Retuerta, Francesc
dc.contributor.authorPalacio, Montse
dc.contributor.authorGratacós Solsona, Eduard
dc.contributor.authorOPTIM-PTL group
dc.date.accessioned2023-03-29T14:28:04Z
dc.date.available2023-03-29T14:28:04Z
dc.date.issued2021-09-28
dc.date.updated2023-03-29T14:28:04Z
dc.description.abstractIntroduction: The majority of women admitted with threatened preterm labour (PTL) do not delivery prematurely. While those with microbial invasion of the amniotic cavity (MIAC) represent the highest risk group, this is a condition that is not routinely ruled out since it requires amniocentesis. Identification of low-risk or high-risk cases might allow individualisation of care, that is, reducing overtreatment with corticosteroids and shorten hospital stay in low-risk women, while allowing early antibiotic therapy in those with MIAC. Benefits versus risks of amniocentesis-based predictor models of spontaneous delivery within 7 days and/or MIAC have not been evaluated. Methods and analysis: This will be a Spanish randomised, multicentre clinical trial in singleton pregnancies (23.0-34.6 weeks) with PTL, conducted in 13 tertiary centres. The intervention arm will consist in the use of amniocentesis-based predictor models: if low risk, hospital discharge within 24 hours of results with no further medication will be recommended. If high risk, antibiotics will be added to standard management. The control group will be managed according to standard institutional protocols, without performing amniocentesis for this indication. The primary outcome will be total antenatal doses of corticosteroids, and secondary outcomes will be days of maternal stay and the occurrence of clinical chorioamnionitis. A cost analysis will be undertaken. To observe a reduction from 90% to 70% in corticosteroid doses, a reduction in 1 day of hospital stay (SD of 2) and a reduction from 24% to 12% of clinical chorioamnionitis, a total of 340 eligible patients randomised 1 to 1 to each study arm is required (power of 80%, with type I error α=0.05 and two-sided test, considering a dropout rate of 20%). Randomisation will be stratified by gestational age and centre.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec721654
dc.identifier.issn2044-6055
dc.identifier.pmid34588268
dc.identifier.urihttps://hdl.handle.net/2445/196209
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-054711
dc.relation.ispartofBMJ Open, 2021, vol. 11, num. 9, p. e054711
dc.relation.urihttps://doi.org/10.1136/bmjopen-2021-054711
dc.rightscc-by-nc (c) Cobo, Teresa et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject.classificationPart prematur
dc.subject.classificationAvaluació del risc per la salut
dc.subject.classificationLíquid amniòtic
dc.subject.classificationInfeccions
dc.subject.classificationServeis de salut maternal
dc.subject.classificationCorticosteroides
dc.subject.classificationEcografia
dc.subject.otherPremature labor
dc.subject.otherHealth risk assessment
dc.subject.otherAmniotic liquid
dc.subject.otherInfections
dc.subject.otherMaternal health services
dc.subject.otherAdrenocortical hormones
dc.subject.otherUltrasonic imaging
dc.titleAssessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study).
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
721654.pdf
Mida:
262.4 KB
Format:
Adobe Portable Document Format